96 related articles for article (PubMed ID: 1355575)
21. P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome.
Tóthová E; Elbertová A; Fricová M; Kafková A; Hlebasková M; Svorcová E; Stecová N; Guman T; Raffac S
Neoplasma; 2001; 48(5):393-7. PubMed ID: 11845985
[TBL] [Abstract][Full Text] [Related]
22. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
[TBL] [Abstract][Full Text] [Related]
23. Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.
Schaich M; Harbich-Brutscher E; Pascheberg U; Mohr B; Soucek S; Ehninger G; Illmer T
Haematologica; 2002 May; 87(5):455-64. PubMed ID: 12010657
[TBL] [Abstract][Full Text] [Related]
24. MDR1 (multidrug resistance) gene expression in adult acute leukemia: correlations with blast phenotype.
Miyachi H; Takemura Y; Yonekura S; Komatsuda M; Nagao T; Arimori S; Ando Y
Int J Hematol; 1993 Jan; 57(1):31-7. PubMed ID: 8477061
[TBL] [Abstract][Full Text] [Related]
25. Expression of resistance genes in acute leukemia.
Zhou DC; Hoang-Ngoc L; Delmer A; Faussat AM; Russo D; Zittoun R; Marie JP
Leuk Lymphoma; 1994; 13 Suppl 1():27-30. PubMed ID: 8075575
[TBL] [Abstract][Full Text] [Related]
26. Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome.
Ino T; Miyazaki H; Isogai M; Nomura T; Tsuzuki M; Tsuruo T; Ezaki K; Hirano M
Leukemia; 1994 Sep; 8(9):1492-7. PubMed ID: 7916390
[TBL] [Abstract][Full Text] [Related]
27. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity.
Marie JP; Zittoun R; Sikic BI
Blood; 1991 Aug; 78(3):586-92. PubMed ID: 1859877
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of the multidrug resistance MDR1 gene expression in clinical leukemia with RT-PCR].
Zhang H; Shi G; Wang J
Zhonghua Nei Ke Za Zhi; 1995 Jul; 34(7):463-7. PubMed ID: 8556928
[TBL] [Abstract][Full Text] [Related]
30. [A clinical study on multidrug resistance gene (MDR1) expression in acute leukemia].
Pu J; Liu H; Lou F
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):655-8. PubMed ID: 8731823
[TBL] [Abstract][Full Text] [Related]
31. MDR1 expression in human leukemia-lymphoma cell lines.
Metge K; Steube K; Uphoff CC; Gignac SM; Drexler HG
Leukemia; 1993 Jun; 7(6):896-7. PubMed ID: 8099136
[TBL] [Abstract][Full Text] [Related]
32. MDR1 gene expression and treatment outcome in acute myeloid leukemia.
Pirker R; Wallner J; Geissler K; Linkesch W; Haas OA; Bettelheim P; Hopfner M; Scherrer R; Valent P; Havelec L
J Natl Cancer Inst; 1991 May; 83(10):708-12. PubMed ID: 2023272
[TBL] [Abstract][Full Text] [Related]
33. Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
Preudhomme C; Lepelley P; Vachee A; Soenen V; Quesnel B; Cosson A; Fenaux P
Leukemia; 1993 Nov; 7(11):1888-90. PubMed ID: 7901457
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
[TBL] [Abstract][Full Text] [Related]
35. MDR1/P-GP expression as a prognostic factor in acute leukemias.
Marie JP; Legrand O
Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
[TBL] [Abstract][Full Text] [Related]
36. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells.
Crouthamel MH; Wu D; Yang Z; Ho RJ
J Pharm Sci; 2006 Dec; 95(12):2767-77. PubMed ID: 16917872
[TBL] [Abstract][Full Text] [Related]
37. Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells.
Marie JP; Brophy NA; Ehsan MN; Aihara Y; Mohamed NA; Cornbleet J; Chao NJ; Sikic BI
Br J Haematol; 1992 Jun; 81(2):145-52. PubMed ID: 1353683
[TBL] [Abstract][Full Text] [Related]
38. MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia.
van den Heuvel-Eibrink MM; Wiemer EA; de Boevere MJ; van der Holt B; Vossebeld PJ; Pieters R; Sonneveld P
Blood; 2001 Jun; 97(11):3605-11. PubMed ID: 11369657
[TBL] [Abstract][Full Text] [Related]
39. HOXA9 gene expression in acute myeloid leukemia.
Li DP; Li ZY; Sang W; Cheng H; Pan XY; Xu KL
Cell Biochem Biophys; 2013; 67(3):935-8. PubMed ID: 23575938
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.
Nooter K; Sonneveld P; Oostrum R; Herweijer H; Hagenbeek T; Valerio D
Int J Cancer; 1990 Feb; 45(2):263-8. PubMed ID: 1968051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
